DGAP-News: HAEMATO AG: 2013: Final IFRS results, sales of

DGAP-News: HAEMATO AG / Key word(s): Final Results/Dividend
HAEMATO AG: 2013: Final IFRS results, sales of EUR 173.57 million,
annual net income of EUR 8.38 million; proposal on the increase in the
dividend from EUR 0.25 to EUR 0.30 per share

14.04.2014 / 10:34

---------------------------------------------------------------------

2013: Final IFRS results, sales of EUR 173.57 million, annual net income of
EUR 8.38 million; proposal on the increase in the dividend from EUR 0.25 to
EUR 0.30 per share

In the financial year 2013 HAEMATO AG, Berlin (ISIN: DE0006190705),
achieved IFRS Group sales of EUR 173.57 m (previous year: EUR 25.04 m) and
profit of EUR 8.38 m (previous year: EUR 7.41 m; thereof non-recurring
profit from sales of property of EUR 7.26 m).

"HAEMATO AG has the potential for further growth of the pharmaceuticals
business, which is characterized by stable cash flows. The management
proposes an increase in the dividend from EUR 0.25 to EUR 0.30 per share
for approval by the Annual General Meeting on May, 28, 2014", says Dr.
Christian Pahl, Member of the Management Board of HAEMATO AG.

About HAEMATO:

HAEMATO AG was founded in 1993 and is a stock exchange quoted
pharmaceutical company. The company is listed on the Frankfurt Stock
Exchange in the Entry Standard (Open Market) and is based in SchÃ¶nefeld,
Germany.

The focus of the business activities lies on the growth markets of patent
free and patent protected medicinal products. Focal points are therapies
for cancer, HIV, cardiovascular and other chronic diseases.


Contact:
HAEMATO AG, Investor Relations
Telefon: +49 (0)30 897 30 86 70
ir@haemato.de


End of Corporate News

---------------------------------------------------------------------

14.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


263048 14.04.2014

DGAP-News: HAEMATO AG: 2013: Final IFRS results, sales of EUR 173.57 million, annual net income of EUR 8.38 million; proposal on the increase in the dividend from EUR 0.25 to EUR 0.30 per share